Literature DB >> 23963683

Protein kinase inhibitor γ reciprocally regulates osteoblast and adipocyte differentiation by downregulating leukemia inhibitory factor.

Xin Chen1, Bryan S Hausman, Guangbin Luo, Guang Zhou, Shunichi Murakami, Janet Rubin, Edward M Greenfield.   

Abstract

The protein kinase inhibitor (Pki) gene family inactivates nuclear protein kinase A (PKA) and terminates PKA-induced gene expression. We previously showed that Pkig is the primary family member expressed in osteoblasts and that Pkig knockdown increases the effects of parathyroid hormone and isoproterenol on PKA activation, gene expression, and inhibition of apoptosis. Here, we determined whether endogenous levels of Pkig regulate osteoblast differentiation. Pkig is the primary family member in murine embryonic fibroblasts (MEFs), murine marrow-derived mesenchymal stem cells, and human mesenchymal stem cells. Pkig deletion increased forskolin-dependent nuclear PKA activation and gene expression and Pkig deletion or knockdown increased osteoblast differentiation. PKA signaling is known to stimulate adipogenesis; however, adipogenesis and osteogenesis are often reciprocally regulated. We found that the reciprocal regulation predominates over the direct effects of PKA since adipogenesis was decreased by Pkig deletion or knockdown. Pkig deletion or knockdown also simultaneously increased osteogenesis and decreased adipogenesis in mixed osteogenic/adipogenic medium. Pkig deletion increased PKA-induced expression of leukemia inhibitory factor (Lif) mRNA and LIF protein. LIF neutralizing antibodies inhibited the effects on osteogenesis and adipogenesis of either Pkig deletion in MEFs or PKIγ knockdown in both murine and human mesenchymal stem cells. Collectively, our results show that endogenous levels of Pkig reciprocally regulate osteoblast and adipocyte differentiation and that this reciprocal regulation is mediated in part by LIF. Stem Cells 2013;31:2789-2799. © AlphaMed Press.

Entities:  

Keywords:  Adipogenesis; Leukemia inhibitory factor; Mesenchymal stem cell; Osteogenesis; Protein kinase inhibitor

Mesh:

Substances:

Year:  2013        PMID: 23963683      PMCID: PMC3930625          DOI: 10.1002/stem.1524

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  72 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

Review 2.  Transcriptional regulation by the phosphorylation-dependent factor CREB.

Authors:  B Mayr; M Montminy
Journal:  Nat Rev Mol Cell Biol       Date:  2001-08       Impact factor: 94.444

3.  The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation.

Authors:  D M Thomas; S A Carty; D M Piscopo; J S Lee; W F Wang; W C Forrester; P W Hinds
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

4.  Reproductive function in protein kinase inhibitor-deficient mice.

Authors:  M Belyamani; E A Gangolli; R L Idzerda
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

5.  Deficient gene expression in protein kinase inhibitor alpha Null mutant mice.

Authors:  E A Gangolli; M Belyamani; S Muchinsky; A Narula; K A Burton; G S McKnight; M D Uhler; R L Idzerda
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

6.  Leukemia inhibitory factor enhances bone formation in calvarial bone defect.

Authors:  S Dazai; S Akita; A Hirano; M A Rashid; S Naito; K Akino; T Fujii
Journal:  J Craniofac Surg       Date:  2000-11       Impact factor: 1.046

7.  Mouse embryonic fibroblasts (MEF) exhibit a similar but not identical phenotype to bone marrow stromal stem cells (BMSC).

Authors:  Hamid Saeed; Hanna Taipaleenmäki; Abdullah M Aldahmash; Basem M Abdallah; Moustapha Kassem
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

8.  Biphasic effects of leukemia inhibitory factor on osteoblastic differentiation.

Authors:  L Malaval; J E Aubin
Journal:  J Cell Biochem Suppl       Date:  2001

9.  A phosphodiesterase inhibitor, pentoxifylline, enhances the bone morphogenetic protein-4 (BMP-4)-dependent differentiation of osteoprogenitor cells.

Authors:  T Tsutsumimoto; S Wakabayashi; T Kinoshita; H Horiuchi; K Takaoka
Journal:  Bone       Date:  2002-09       Impact factor: 4.398

10.  The role of an endogenous PKA inhibitor, PKIalpha, in organizing left-right axis formation.

Authors:  M Kawakami; N Nakanishi
Journal:  Development       Date:  2001-07       Impact factor: 6.868

View more
  4 in total

Review 1.  Role of bone marrow adipocytes in leukemia and chemotherapy challenges.

Authors:  Azin Samimi; Majid Ghanavat; Saeid Shahrabi; Shirin Azizidoost; Najmaldin Saki
Journal:  Cell Mol Life Sci       Date:  2019-02-04       Impact factor: 9.261

2.  Wear Particle-induced Priming of the NLRP3 Inflammasome Depends on Adherent Pathogen-associated Molecular Patterns and Their Cognate Toll-like Receptors: An In Vitro Study.

Authors:  Givenchy W Manzano; Brian P Fort; George R Dubyak; Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

3.  Obesity is associated with depot-specific alterations in adipocyte DNA methylation and gene expression.

Authors:  Si Brask Sonne; Rachita Yadav; Guangliang Yin; Marlene Danner Dalgaard; Lene Secher Myrmel; Ramneek Gupta; Jun Wang; Lise Madsen; Shingo Kajimura; Karsten Kristiansen
Journal:  Adipocyte       Date:  2017-04-18       Impact factor: 4.534

Review 4.  The emerging role of leukemia inhibitory factor in cancer and therapy.

Authors:  Cen Zhang; Juan Liu; Jianming Wang; Wenwei Hu; Zhaohui Feng
Journal:  Pharmacol Ther       Date:  2020-11-28       Impact factor: 12.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.